1. Lymphomatoid granulomatosis--a report on four cases: evidence for B phenotype of the tumoral cells
- Author
-
Françoise Berger, J.F. Cordier, Ph. Tanière, R. Loire, D. Vitrey, Françoise Thivolet-Béjui, and S. Isaac
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,Epstein-Barr Virus Infections ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Lymphomatoid granulomatosis ,In situ hybridization ,Biology ,medicine.disease_cause ,Herpesviridae ,Virus ,Immunoenzyme Techniques ,Antigens, CD ,hemic and lymphatic diseases ,medicine ,Humans ,Lung ,In Situ Hybridization ,Histiocyte ,B-Lymphocytes ,Membrane Glycoproteins ,Lysosome-Associated Membrane Glycoproteins ,Lymphomatoid Granulomatosis ,Middle Aged ,medicine.disease ,Epstein–Barr virus ,Phenotype ,Epstein-Barr Virus Nuclear Antigens ,Membrane protein ,Female - Abstract
Four cases of lymphomatoid granulomatosis are reported, three of them involving the lung. Histological features included a true angiocentric and angiodestructive polymorphic cellular proliferation. This included histiocytes, plasma cells, many reactive T-cells and rare large, atypical cells which were of the B phenotype. Epstein-Barr virus was detected in the atypical cells by in situ hybridization in three cases, with expression of both latent membrane proteins (LMP)-1 and Epstein-Barr nuclear antigen-2 in two cases and expression of only LMP-1 in the third case. Expression of both of these proteins suggests a defect in the T-cell-mediated immunity and that Epstein-Barr virus is not only a silent passenger but may also be involved in the pathogenesis of the disease. This could have implications for therapy.
- Published
- 1998
- Full Text
- View/download PDF